Cannabinoid Therapeutics : From Chronic Pain to COVID-19 | Healthy Seminars

Cannabinoid Therapeutics : From Chronic Pain to COVID-19

Theralogix LLC

 

Cannabinoid Therapeutics: From Chronic Pain to COVID-19

- Presented by Mark H. Ratner, MD - Chief Science Officer Theralogix, LLC

 
PLEASE NOTE: this webinar originally scheduled for today, June 2nd HAS BEEN POSTPONED to June 11th.

 

Cannabinoid Therapeutics : From Chronic Pain to COVID-19

* This webinar is brought to you by Theralogix
PLEASE NOTE: this webinar originally scheduled for today, June 2nd HAS BEEN POSTPONED to June 11th.

 

Register your place at this FREE 1-hour Live Webinar on Thursday, June 11th at 3:00pm PDT

 

 

Objectives:

  • Understanding the Human Endocannabinoid System
  • CBD – Efficacy and Safety
  • Palmitoylethanolamide (PEA) – An Endogenous AND Exogenous Cannabinoid
  • Cannabinoids for Chronic Pain and Immune Modulation
 

Register your place at this FREE Live Webinar on Thursday, June 11th at 3:00pm PDT

 
Mark H. Ratner

Dr. Mark H. Ratner is the founder and Chief Science Officer of Theralogix. A practicing physician for more than 30 years, he pursued his undergraduate studies and a Master’s degree program in Nutrition at Cornell University. His medical school and graduate medical training were completed at Tulane University School of Medicine. Dr. Ratner previously served as the Director of Male Reproductive Medicine at Shady Grove Fertility Center in Washington, DC. He has served as an investigator for numerous drug development trials, and currently coordinates product development at Theralogix. In addition, he oversees the use of Theralogix products in several NIH-funded, university-based clinical trials.

 

 

* This webinar is brought to you by Theralogix

 


Theralogix, LLC

Theralogix LLC

Theralogix shares a common value with the thousands of healthcare providers and consumers that we serve each and every day. In a world of endless choices, high-quality, research-based nutritional supplements must stand out and provide the confidence that healthcare providers and consumers have come to expect.

When Theralogix was established in 2002, there was a growing awareness that nutritional supplements, proper nutrition, and a healthy lifestyle all play important roles in overall health and well-being. At that time, there was also a growing awareness of many companies on the market who were producing less-than-trustworthy products. With very little oversight, it was difficult for our founders - a group of well-renowned, industry-leading physicians and scientists - to find products they felt comfortable recommending to their patients, families, and friends. From Day 1, our guiding principles have been to only produce formulations based upon high-quality scientific research and manufacture products with the highest verifiable quality.

Over 15 years and 30 products later, thousands of healthcare providers and patients have come to trust Theralogix nutritional supplements across a variety of healthcare specialties, including fertility, women's health, urology, rheumatology and general health. Theralogix remains committed to following the science where ever it leads, and will continue to provide affordable products that are evidence-based, content-certified and always best in class.

 

 

Upcoming 1-hour Live Webinar:

Theralogix Lecture 2

* This webinar is brought to you by Theralogix

 

Micronutrients for Viral Infection: Separating Fact from Fiction During COVID-19

- Presented by Mark H. Ratner, MD - Chief Science Officer Theralogix, LLC

 

Register your place at this FREE Live Webinar on Tuesday, June 16th at 3:00pm PDT

 

 

Objectives:

  • Prevention and Treatment of Viral Infection
  • Mechanisms of Anti-viral Activity
  • Innate vs. Adaptive Immunity in Viral Infections
  • Micronutrients : What Works – and what’s Worthless?
 

Register your place at this FREE Live Webinar on Tuesday, June 16th at 3:00pm PDT